SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs >

Novus Therapeutics Inc (NVUS)

NVUS RSS Feed
Add NVUS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/29/2017 3:11:23 AM - Followers: 20 - Board type: Free - Posts Today: 0


Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-01 is currently being developed as an improved treatment option for acute otitis externa. OP-02 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. OP-02 is a combination drug product, which comprises two components: surfactant dipalmitoylphosphatidylcholine and a spreading agent cholesteryl palmitate. The product is sprayed through the nostrils toward the opening of the Eustachian tube at the back of the nasal cavity.


36.9% of Tokai Pharmaceuticals shares are owned by institutional investors. 39.9% of shares are owned by insiders.


Novus Therapeutics is a pharmaceutical company focusing on the acquisition, development, and commercialization of ear, nose, and throat (ENT) products. The company has two technologies, each of which has the potential to be developed for multiple ENT indications. The company's lead product is a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), conditions that affect more than 700 million people around the world every year. Otitis media is one of the most common diseases seen by pediatricians and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing a foam-based combination drug-product delivered to the external ear canal that is an improved treatment option for acute otitis externa ("swimmers ear").

HeadquartersIrvine, California, United States

Investor Contacts

Novus Therapeutics, Inc.
Investor Relations
Tel: (949) 238-8090
investors@novustherapeutics.com
SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
NVUS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
NVUS News: Novus Therapeutics Reports Second Quarter 2017 Results 08/09/2017 06:37:00 PM
NVUS News: Novus Therapeutics Reports Second Quarter 2017 Results 08/09/2017 06:08:00 PM
NVUS News: Novus Therapeutics Announces Change in Management 07/10/2017 06:30:00 AM
NVUS News: Novus Therapeutics Announces Change in Management 07/10/2017 06:30:00 AM
NVUS News: Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 06/12/2017 08:00:00 AM
PostSubject
#581   Chart Shaping up for reversal. if we focus2011 06/29/17 03:11:23 AM
#580   Employee compensation in Shares.. at least they think focus2011 06/20/17 09:38:11 PM
#579   Future Parabolic Runner IMO.. but from where? focus2011 05/25/17 03:15:16 PM
#578   been adding drips and drabs.. only couple hundred focus2011 05/25/17 03:14:50 PM
#577   Tiny Float, I mean really Tiny focus2011 05/25/17 03:14:15 PM
#576   Let's get this changed to NVUS focus2011 05/25/17 03:14:00 PM
#575   Merger NEW out! ListenToMe 05/10/17 06:04:31 AM
#574   TKAI is seeking approval of a reverse stock l2 hunter 05/09/17 02:22:20 PM
#573   Time to add? Yo-Yo 05/06/17 05:30:19 PM
#572   No volume at all since a week, how THEBELGIAN77 04/27/17 10:11:57 AM
#571   Share structure: 22.64M issued but 49,9% locked by insiders THEBELGIAN77 04/20/17 04:38:33 AM
#570   hi there, I'm in with 7000 shares @ 0.668$ THEBELGIAN77 04/17/17 01:50:24 PM
#569   Loading opportunity QUANTUM314 04/09/17 11:20:49 PM
#568   TKAI...trying to read and figure out what happened novicetrader 04/08/17 04:53:00 PM
#567   To get convos going where do we think corncakes0 02/15/17 05:08:12 PM
#566   TKAI's draft proxy filing is under 30 day Rock_nj 01/28/17 07:00:14 AM
#565   Nice action here today LightandShadow 01/25/17 04:07:43 PM
#564   I had a great profit off the last TheMagnetar 01/24/17 10:13:29 AM
#563   Where do you think we go? $2? BullishGuru 01/24/17 08:01:46 AM
#562   TKAI NEWS Proxy Statement - Merger or Acquistion l2 hunter 01/24/17 06:54:59 AM
#561   Filing expected today or tomorrow per PR firm. Rock_nj 01/23/17 02:25:42 PM
#560   Sounds like it will be showtime very soon Rock_nj 01/19/17 06:14:53 AM
#559   Too manipulated. Watching though. TKAI likes Lone Wolf 01/14/17 11:44:00 AM
#558   Are you still in $TKAI Lone Wolf? Rock_nj 01/14/17 11:36:18 AM
#557   Conference call announcement coming soon. By end Rock_nj 01/11/17 05:58:10 AM
#556   I am certainly looking forward to hearing what Rock_nj 01/06/17 10:38:21 PM
#555   Hoping the CC is next week as they corncakes0 01/06/17 10:35:04 PM
#554   Otic Pharma, Ltd. just filed a new activist Rock_nj 01/05/17 03:44:16 PM
#553   Otic Pharma merging into Tokai Nasdaq shell Rock_nj 01/04/17 03:17:06 PM
#552   TKAI is heating up. Going to be Rock_nj 01/04/17 11:13:01 AM
#551   TKAI short covering rally has begun ahead of Rock_nj 01/03/17 03:12:54 PM
#550   Tax loss selling of TKAI is almost over. Rock_nj 12/30/16 01:46:04 PM
#549   Add to these, the end of tax loss Rock_nj 12/30/16 12:14:52 AM
#548   Two big developments for TKAI early in January: Rock_nj 12/29/16 10:48:48 AM
#547   TKAI is going to spike once the conference Rock_nj 12/28/16 12:33:47 PM
#546   Boston-based Tokai throws in the towel, sells public Rock_nj 12/23/16 03:48:51 PM
#545   TKAI ambling along until the conference call in Rock_nj 12/23/16 03:37:39 PM
#544   Right back up again to the $1.20s after Rock_nj 12/23/16 09:41:26 AM
#543   Gapping down aftr yesterday afternoon's sustained dumpfest. Lonewolf1 12/23/16 09:19:10 AM
#542   The problem is, that this Otic Pharma has rogueT 12/23/16 03:39:20 AM
#541   Conference Call Information Rock_nj 12/23/16 12:23:56 AM
#540   I don't see how this has anywhere to Rock_nj 12/22/16 11:07:58 PM
#539   Surprised here too. When 3 times the Lone Wolf 12/22/16 08:27:26 PM
#538   Just up 20% from the bottom. christalball 12/22/16 08:17:20 PM
#537   Surprised by EOD. christalball 12/22/16 08:15:37 PM
#536   * * $TKAI Video Chart 12-22-16 * * ClayTrader 12/22/16 05:18:08 PM
#535   Flippers out. Grind higher. This appears Rock_nj 12/22/16 04:50:50 PM
#534   Nice inverted hammer here. Should see a huge Wild Wild West 12/22/16 04:44:22 PM
#533   TKAI going into. Eod $1.40 range i think. l2 hunter 12/22/16 02:54:49 PM
#532   Looking a little better. christalball 12/22/16 02:47:59 PM
PostSubject